Boehringer Ingelheim to Work with Xybion’s Preclinical Gold Standard Solution, Pristima XD, to Enhance Lab Operations

Industry: Computer Software/Services

Xybion's Preclinical Gold Standard Pristima XD Unifies and Enhances Laboratory Efficiency and Data Integrity for Boehringer Ingelheim.

Princeton, N.J. (PRUnderground) March 29th, 2021

Xybion Corporation announced today it is partnering with Boehringer Ingelheim to enhance process efficiency and data integrity in the Preclinical lab. This end to end preclinical gold standard solution helps with study planning, protocol, study execution, animal management, data management and regulatory submissions globally.

Boehringer Ingelheim’s mission is to create breakthrough therapies that change lives. Since its founding in 1885, Boehringer Ingelheim is independent and family-owned and has the freedom to pursue its long-term vision, looking ahead to identify the health challenges of the future and targeting those areas of need where we can do the most good. As a world-leading, research-driven pharmaceutical company, more than 51,000 employees create value through innovation daily for our three business areas: Human Pharma, Animal Health and Biopharmaceutical Contract Manufacturing.

The preclinical lab processes and data management are a critical part of Boehringer Ingelheim’s development, and the enhanced processes will make Good Laboratory Practice (GLP) as well as non-GLP studies more efficient. “Boehringer Ingelheim is excited to partner with Xybion and its end to end, fully unified solution, which will support us to run nearly the entire process from a single system. This improves the business user experience significantly, offers more flexibility and simplifies the IT ecosystem through a single platform instead of operating multiple systems,” says Dr. Robin Stierkat, IT Project manager of Boehringer Ingelheim.

Kamal Biswas, President and COO of Xybion says, “We are very excited to start this partnership. Xybion’s Pristima XD gold standard preclinical solution creates an end-to-end digital laboratory execution environment with connected workflows, innovative technology-driven automation, integrated instruments, and data management for the entire preclinical operation.”

“The cloud based Digital Lab platform helps Boehringer Ingelheim to achieve the goal to provide more health and improve the lives of both humans and animals, while reducing complexity in our own IT landscape,” adds Dr. Robin Stierkat.

About Xybion Corporation

Xybion is a leading SaaS solutions company dedicated to helping life sciences and health systems companies accelerate the conversion of today’s inventions into tomorrow’s approved medicines to save lives and keep employees safe. Through intelligently designed cloud platform we help companies accelerate digital transformation of its processes, speed up innovation, optimize operations, reduce compliance risks, and achieve significant cost savings. Serving more than 160 customers including 100% of the top 20 global biopharmaceutical companies in 25 countries, we have the global scale and expertise to bring employees around the world to help companies in life sciences, healthcare, manufacturing, workplace health, and government. We put our expertise in action every day to help companies transform the digital workplace. Our unique solutions focus on employee health and safety, EHS, integrated preclinical lab management, early-stage drug discovery, digital lab solution, regulatory compliance, GRC, quality management, predictive compliance, content management, and systems validation.

Learn more about Xybion at https://www.xybion.com/

Print Friendly, PDF & Email

Press Contact

Name
Joseph Kalina
Phone
609-512-5790 x316
Email
Contact Us
Website
https://www.xybion.com/